29.19

2.70% -0.81

After Hours: 29.19

Tyra Biosciences Inc (TYRA)

Overview News Price History Option Chain Financials Discussions Forecast

Tyra Biosciences Inc stock is traded at $29.19, with a volume of 1.87M. It is down -2.70% in the last 24 hours and up +1.46% over the past month. Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Previous Close:

$30.00

Open:

$33.81

24h Volume:

1.87M

Relative Volume:

3.07

Market Cap:

$1.56B

Revenue:

Net Income/Loss:

$-83.74M

P/E Ratio:

-18.13

EPS:

-1.61

Net Cash Flow:

$-64.98M

1W Performance:

-0.92%

1M Performance:

+1.46%

6M Performance:

+175.38%

1Y Performance:

+142.44%

1-Day Range:

$24.88

$33.99

1-Week Range:

$24.88

$33.99

52-Week Range:

$6.42

$33.99

Tyra Biosciences Inc Stock (TYRA) Company Profile

Name

Tyra Biosciences Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

(619) 728-4760

Address

2656 STATE STREET, CARLSBAD

Employee

Twitter

Next Earnings Date

2025-03-26

Latest SEC Filings

TYRA's Discussions on Twitter

Compare TYRA vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TYRA Tyra Biosciences Inc	29.19	1.60B	0	-83.74M	-64.98M	-1.61
VRTX Vertex Pharmaceuticals Inc	465.02	117.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	783.65	82.35B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	833.54	51.64B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	308.48	42.58B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.42	38.87B	4.98B	69.60M	525.67M	0.5198

Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-10-26	Initiated	William Blair	Outperform
Jan-28-26	Initiated	Barclays	Overweight
Sep-03-25	Initiated	Raymond James	Strong Buy
May-21-25	Resumed	Piper Sandler	Overweight
Jan-07-25	Initiated	UBS	Buy
Oct-18-24	Upgrade	BofA Securities	Neutral → Buy
Aug-15-24	Initiated	Piper Sandler	Overweight
Dec-15-23	Downgrade	BofA Securities	Buy → Neutral
Jun-30-23	Initiated	Wedbush	Outperform
Feb-03-23	Initiated	Oppenheimer	Outperform
Jun-23-22	Initiated	H.C. Wainwright	Buy
Mar-08-22	Upgrade	Jefferies	Hold → Buy
Nov-08-21	Downgrade	Jefferies	Buy → Hold
Oct-11-21	Initiated	BofA Securities	Buy
Oct-11-21	Initiated	Cowen	Outperform
Oct-11-21	Initiated	Jefferies	Buy

View All

Tyra Biosciences Inc Stock (TYRA) Latest News

02:33 AM

Tyra Biosciences (NASDAQ:TYRA) Sets New 12-Month HighTime to Buy? - MarketBeat

02:33 AM

01:57 AM

Wedbush Raises Price Target on Tyra Bioscience to $53 From $37, Keeps Outperform Rating - marketscreener.com

01:57 AM

Feb 11, 2026

Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Feb 11, 2026

Feb 10, 2026

Can Tyra Biosciences Inc. continue delivering strong returnsTrade Analysis Report & Weekly Stock Performance Updates - mfd.ru

Feb 10, 2026

William Blair initiates coverage on Tyra Biosciences stock with Outperform rating - Investing.com Canada

Feb 10, 2026

Wedbush Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $37 - 富途牛牛

Feb 10, 2026

William Blair Initiates TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $59.62 - 富途牛牛

Feb 10, 2026

DKAs Burden The Clinical and Economic Impact - William Blair

Feb 10, 2026

Tyra Biosciences stock hits 52-week high, reaching $31.0 By Investing.com - Investing.com South Africa

Feb 10, 2026

Feb 09, 2026

Tyra Biosciences stock hits 52-week high, reaching $31.0 - Investing.com

Feb 09, 2026

Feb 07, 2026

Is Tyra Biosciences Inc a turnaround storyWeekly Trading Summary & High Accuracy Trade Signal Alerts - baoquankhu1.vn

Feb 07, 2026

AlphaQuest LLC Has $421,000 Holdings in Tyra Biosciences, Inc. $TYRA - MarketBeat

Feb 07, 2026

Feb 06, 2026

Resistance Check: Is Tyra Biosciences Inc a strong candidate for buy and holdJuly 2025 Update & High Accuracy Trade Signal Alerts - baoquankhu1.vn

Feb 04, 2026

Feb 03, 2026

Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $50 - 富途牛牛

Feb 03, 2026

Jefferies Financial Group Forecasts Strong Price Appreciation for Tyra Biosciences (NASDAQ:TYRA) Stock - MarketBeat

Feb 03, 2026

Feb 02, 2026

Top Growth Stocks To Watch Now – January 31st - Defense World

Feb 02, 2026

Jan 31, 2026

Big Picture: What are the risks of holding Tyra Biosciences IncMarket Risk Summary & Real-Time Sentiment Analysis - baoquankhu1.vn

Jan 31, 2026